Biodesix, Inc. (BDSX) Financials
BDSX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 99.1 million | 94.5 million |
2023-09-30 | 86.8 million | 88.2 million |
2023-06-30 | 77.6 million | 84.6 million |
2023-03-31 | 80.8 million | 76.2 million |
BDSX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.5 million | 1.1 million |
2023-09-30 | -9.7 million | 954000 |
2023-06-30 | -5.5 million | 1.1 million |
2023-03-31 | -15.4 million | 2.3 million |
BDSX Net Income
No data available :(
BDSX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 26.4 million | - | 25.4 million |
2023-09-30 | 19.8 million | - | 25.7 million |
2023-06-30 | 17.4 million | - | 20.3 million |
2023-03-31 | 25.3 million | - | 13.8 million |
BDSX Shares Outstanding
BDSX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 3.0 million | 1.9 million | 16.3 million | - |
2023-09-30 | 5.9 million | 1.9 million | 15.5 million | - |
2023-06-30 | 6.5 million | 2.9 million | 16.7 million | - |
2023-03-31 | 7.7 million | 3.3 million | 19.0 million | 19.0 million |
BDSX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 14.7 million | 3.4 million |
2023-09-30 | 13.5 million | 3.2 million |
2023-06-30 | 11.9 million | 3.2 million |
2023-03-31 | 9.1 million | 3.2 million |
BDSX
Price: $1.24
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -2.26
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 306900
Market Capitalization: 135.7 million